Improve the outcome of autologous hematopoietic cell transplantation!

被引:4
作者
Blume, KG [1 ]
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
关键词
D O I
10.1016/S1083-8791(01)70013-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:527 / 531
页数:5
相关论文
共 19 条
[1]   High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience [J].
Cao, TM ;
Horning, SF ;
Negrin, RS ;
Hu, WW ;
Johnston, LF ;
Taylor, TL ;
Shizuru, JA ;
Hoppe, RT ;
Brown, BW ;
Blume, KG ;
Stockerl-Goldstein, K .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (05) :294-301
[2]   Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma [J].
Flinn, IW ;
O'Donnell, PV ;
Goodrich, A ;
Vogelsang, G ;
Abrams, R ;
Noga, S ;
Marcellus, D ;
Borowitz, M ;
Jones, R ;
Ambinder, RF .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (06) :628-632
[3]   High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission [J].
Freedman, AS ;
Gribben, JG ;
Neuberg, D ;
Mauch, P ;
Soiffer, RJ ;
Anderson, KC ;
Pandite, L ;
Robertson, MJ ;
Kroon, M ;
Ritz, J ;
Nadler, LM .
BLOOD, 1996, 88 (07) :2780-2786
[4]   IMMUNOLOGICAL PURGING OF MARROW ASSESSED BY PCR BEFORE AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR B-CELL LYMPHOMA [J].
GRIBBEN, JG ;
FREEDMAN, AS ;
NEUBERG, D ;
ROY, DC ;
BLAKE, KW ;
WOO, SD ;
GROSSBARD, ML ;
RABINOWE, SN ;
CORAL, F ;
FREEMAN, GJ ;
RITZ, J ;
NADLER, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (22) :1525-1533
[5]   FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE, AND CYCLOPHOSPHAMIDE PLUS AUTOGRAFTING IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA [J].
HORNING, SJ ;
NEGRIN, RS ;
CHAO, NJ ;
LONG, GD ;
HOPPE, RT ;
BLUME, KG .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (12) :2552-2558
[6]   High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial [J].
Horning, SJ ;
Negrin, RS ;
Hoppe, RT ;
Rosenberg, SA ;
Chao, NJ ;
Long, GD ;
Brown, BW ;
Blume, KG .
BLOOD, 2001, 97 (02) :404-409
[7]  
Horwitz SM, 2000, BLOOD, V96, p384A
[8]   Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma - Long-term results of a clinical trial [J].
Hsu, FJ ;
Caspar, CB ;
Czerwinski, D ;
Kwak, LW ;
Liles, TM ;
Syrengelas, A ;
TaidiLaskowski, B ;
Levy, R .
BLOOD, 1997, 89 (09) :3129-3135
[9]   Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion [J].
Magni, M ;
Di Nicola, M ;
Devizzi, L ;
Matteucci, P ;
Lombardi, F ;
Gandola, L ;
Ravagnani, F ;
Giardini, R ;
Dastoli, G ;
Tarella, C ;
Pileri, A ;
Bonadonna, G ;
Gianni, AM .
BLOOD, 2000, 96 (03) :864-869
[10]   Results of high-dose therapy and autologous bone marrow stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: International index high and high-intermediate risk group [J].
Nademanee, A ;
Molina, A ;
ODonnell, MR ;
Dagis, A ;
Snyder, DS ;
Parker, P ;
Stein, A ;
Smith, E ;
Planas, I ;
Kashyap, A ;
Spielberger, R ;
Fung, H ;
Wong, KK ;
Somlo, G ;
Margolin, K ;
Chow, W ;
Sniecinski, I ;
Vora, N ;
Blume, KG ;
Niland, J ;
Forman, SJ .
BLOOD, 1997, 90 (10) :3844-3852